Skip to Main Content

Paper Details

Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID).
J Clin Oncol
38
2021
Author NameAffiliation
Amit Bahl
Vincent KhooThe Royal Marsden NHS Foundation Trust
  • 1 - 2

Datasets

Release 1.2